Home
/
BioAtla, Inc.
/
Financials
/
Quarterly
BioAtla, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BioAtla, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
$0
Nov 7, 2023
Q2
2023
Jun 30, 2023
$0
Aug 1, 2023
Q1
2023
Mar 31, 2023
$0
May 11, 2023
Q3
2023
Sep 30, 2022
$0
Nov 7, 2023
Q2
2023
Jun 30, 2022
$0
Aug 1, 2023
Q1
2023
Mar 31, 2022
$0
May 11, 2023
Q3
2022
Sep 30, 2021
$300.0K
Nov 4, 2022
Q2
2022
Jun 30, 2021
$300.0K
Aug 9, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($15.78M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($18.71M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($15.33M)
May 6, 2025
Q3
2025
Sep 30, 2024
($10.59M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($21.07M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($23.23M)
May 6, 2025
Q3
2024
Sep 30, 2023
($33.33M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($35.75M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($27.46M)
May 14, 2024
Q3
2023
Sep 30, 2022
($25.78M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($28.91M)
Aug 1, 2023
Q1
2023
Mar 31, 2022
($24.25M)
May 11, 2023
Q3
2022
Sep 30, 2021
($22.93M)
Nov 4, 2022
Q2
2022
Jun 30, 2021
($30.38M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($18.70M)
May 5, 2022
Q3
2021
Sep 30, 2020
($11.63M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($6.22M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($1.60M)
May 12, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($13.79M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($18.65M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($17.61M)
May 6, 2025
Q3
2025
Sep 30, 2024
($11.27M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($21.97M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($24.46M)
May 6, 2025
Q3
2024
Sep 30, 2023
($35.02M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($37.20M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($28.93M)
May 14, 2024
Q3
2023
Sep 30, 2022
($26.18M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($29.06M)
Aug 1, 2023
Q1
2023
Mar 31, 2022
($24.35M)
May 11, 2023
Q3
2022
Sep 30, 2021
($23.70M)
Nov 4, 2022
Q2
2022
Jun 30, 2021
($30.46M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($18.80M)
May 5, 2022
Q3
2021
Sep 30, 2020
($8.02M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($4.52M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($1.11M)
May 12, 2021